Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania

Peer Review reports

Original Submission
18 Jan 2021	Submitted	Original manuscript
27 May 2022	Reviewed	Reviewer Report - Andrew Embleton-Thirsk
12 Nov 2022	Author responded	Author comments - Stellah G Mpagama
Resubmission - Version 2
12 Nov 2022	Submitted	Manuscript version 2
22 Nov 2022	Author responded	Author comments - Stellah G Mpagama
Resubmission - Version 3
22 Nov 2022	Submitted	Manuscript version 3
21 Feb 2023	Author responded	Author comments - Stellah G Mpagama
Resubmission - Version 4
21 Feb 2023	Submitted	Manuscript version 4
Publishing
10 Mar 2023	Editorially accepted
1 Apr 2023	Article published	10.1186/s40814-023-01281-7

Back to article page